EUCTR2004-000476-13-IT进行中（未招募）不适用
ong term open label extension trial for subjects completing the phase 3 trial of fesoterodine SP583 for the treatment of overactive bladder syndrome
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,080
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Tocilizumab i.v. monthly in patients with pcJIAEUCTR2011-001097-25-DERoche Pharma AG
进行中（未招募）
1 期
A long-duration study to assess the safety and effectiveness of NBI-827104 in children with Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep.Epileptic Encephalopathy with Continuous Spike-and-Wave During Sleep (EECSWS)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2021-006788-11-DKeurocrine Biosciences, Inc.24
进行中（未招募）
1 期
ong-term extension study of the safety and pharmacokinetics of QCC374 in PAH patientsMedDRA version: 20.0Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary arterial hypertensionEUCTR2016-001411-20-GBovartis Pharma AG5
进行中（未招募）
1 期
ong-term extension study of the safety and pharmacokinetics of QCC374 in PAH patientsMedDRA version: 20.0 Level: PT Classification code 10064911 Term: Pulmonary arterial hypertension System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary arterial hypertensionEUCTR2016-001411-20-DEovartis Pharma AG5
进行中（未招募）
1 期
An open label extension trial to investigate the safety and tolerability of long-term treatment with transdermal rotigotine in subjects with idiopathic restless legs syndromeEUCTR2005-002611-25-GBSCHWARZ BIOSCIENCES GmBH420